FDA 483 - Envita Fertility Center - October 06, 2023

Envita Fertility Center in Laguna Hills, CA, a reproductive fertility center, was cited for two observations during an FDA inspection. The firm was found to have included identifying donor information in HCT/P records and to have implemented donor eligibility procedures without proper review and approval by a responsible person. These issues indicate deficiencies in donor privacy and procedural control.